Advanced technology is increasingly in the public eye following the announcement that the New Zealand government will create an organisation to deliver research and build capabilities and commercial outreach in this field.  

It has been said this new public research organisation (PRO) will focus on advanced technologies such as artificial intelligence, synthetic biology, aerospace, medical technology and gene and quantum technology. The move to create it presents an opportunity for New Zealand to position itself as a world leader in research across these specific areas.  

Most advanced countries have a science policy that outlines what technologies they should take a leading role in researching.

Scion’s view is that the proposed PRO has the opportunity to fill that role for NZ – to continue to define our own research direction as new technologies are developed. Smarter use of advanced technologies and more investment in capital will enable New Zealand businesses to be internationally competitive. 

This change is part of reforms aimed at modernising our innovation, technology and science system, to streamline our R&D and ensure it is focused on meeting NZ’s future needs.

However there is much discussion to be had on what the new PRO will look like, and many questions around what specific advanced technologies matter most to NZ.

In Scion’s view, these include: 

• Gene tech that will transform agriculture and medicine
• Artificial intelligence and robotics across the agritech and food tech industries
• Advanced manufacturing
• Advanced materials such as biochemicals and bioplastics
• Energy tech developments
• Quantum computing

World-leading gene editing research will benefit NZ

^{Scion has launched the world's first field trial of gene-edited conifers, as part of research aimed at improving wood quality and producing materials to support New Zealand’s bioeconomy.}

The organisation has developed and implemented an advanced gene-editing technique known as CRISPR that lets scientists turn off a specific gene within the pine’s complex genome. This helps them understand what that gene does – which in turn builds understanding of how wood develops.

Two sets of trees have been planted, each with a separate gene turned off. This aims to enhance timber quality and improve the process of converting wood into fibre (pulping) and sustainable chemical feedstocks for the bioeconomy.

One of these genes is involved in the synthesis of hemicellulose, a renewable biopolymer (a molecule produced by plants with many versatile, high-value applications. The other is involved in the development of compression wood, which forms on leaning or bent stems to straighten them up.

Compression wood behaves differently from normal wood during timber processing, leading to issues such as warping and reduced strength, as well as making the extraction of fibre and chemicals more difficult.

The trees in this trial were initially cultivated in a contained greenhouse, where their wood underwent a comprehensive analysis.

This research yielded unique and fundamental insights into the mechanisms of cell wall formation.

The trees have subsequently been planted in Scion’s Environment Protection Agency-approved GMO field test containment facility to help scientists better understand how they perform under real-world conditions and to collect sufficient wood for relevant biomechanical experiments.

Scion senior scientist Glenn Thorlby says the trees’ growth and development continue to be meticulously monitored.

“This research will allow us to produce trees that, with optimised wood properties, will support the export of high-value timber and the biomass needed to replace petrochemicals as New Zealand transitions to a low-emissions sustainable bioeconomy.

Additionally, Scion has also developed gene-edited Douglas-fir to create sterile trees that could be planted without the risk of exacerbating New Zealand’s wilding pine issue. These sterile trees would potentially act as a form of biocontrol for future genetically modified trees.

“This will enable Douglas-fir to grow normally but not reproduce, helping limit its spread,” Glenn says. “By targeting reproductive genes, we offer a potential solution to New Zealand’s wilding pine problem.”